Page last updated: 2024-09-04

carbapenems and ro13-9904

carbapenems has been researched along with ro13-9904 in 33 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(ro13-9904)
Trials
(ro13-9904)
Recent Studies (post-2010) (ro13-9904)
7,3551475,2776,8157982,755

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.03)18.7374
1990's6 (18.18)18.2507
2000's3 (9.09)29.6817
2010's13 (39.39)24.3611
2020's10 (30.30)2.80

Authors

AuthorsStudies
Dworkin, RJ; Kennedy, SL; Sachdeva, M; Sande, MA; Tureen, JH1
Edwards, JR; Nairn, K; Shepherd, GL1
Chmelik, V; Featherstone, A; Pfausler, B; Schmutzhard, E; Vukmirovits, G; Williams, KJ1
Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P1
Verbist, L; Verhaegen, J1
Cars, O; Löwdin, E; Odenholt, I1
Manzor, O; Pawlak, J; Saravolatz, L1
Anthony, L; Appelbaum, PC; Credito, K; Ednie, LM; Hoellman, DB; Jacobs, MR; Kelly, LM1
Cravarezza, P; Donati, P; Franchino, L; Grassi, V; Pozzi, A; Prometti, P; Ravizzola, G; Romanelli, G; Zulli, R1
Donskey, CJ; Pultz, NJ; Stiefel, U1
Alış, EE; Cengiz, M; Ekici, S; Turan, G1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E1
Choi, SH; Chung, JW; Kim, MN; Kim, SH; Kim, YS; Lee, SO; Sung, H; Woo, JH1
Apter, S; Eviatar, T; Grossman, E; Hoffman, C; Keller, N; Rosman, Y; Thaler, M1
Bao, Y; Cai, Y; Chai, T; Gao, J; Li, X; Ma, R; Zhao, X; Zhou, Y1
Hong, MT; Seifert, CF1
Bethel, CR; Bonomo, RA; Doi, Y; Endimiani, A; Kasraian, S; Pires, J; Sendi, P; Taracila, M; Tinguely, R1
Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC1
Fisher, K; Juang, P; Kollef, MH; Micek, ST; Trupka, T1
Chen, SL; Heng, ST; Lye, DC; Ng, TM; Wong, JGX1
Almirante, B; Escolà-Vergé, L; González-López, JJ; Larrosa, N; Len, O; Los-Arcos, I; Pigrau, C; Viñado, B1
Murray, BE; Singh, KV1
Azougagh, K; Barbier, F; Boulain, T; Boutrot, M; Guinard, J1
Harris, PNA; Henderson, A; Paterson, DL1
Maquieira, Á; Morais, S; Peña-Mendizabal, E1
Cisera, K; Hughes, C; Rogers, B; Taylor, L; Xie, O1
Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Ohashi, W; Sakanashi, D; Shibata, Y; Shiota, A; Suematsu, H; Watanabe, H; Yamagishi, Y1
Akeda, Y; Arakawa, Y; Minoura, K; Miyamoto, K; Onda, M; Shoji, M; Tomono, K; Tsuchiya, T; Yamabe, K1
Cerboni, G; Corsica, G; De Luca, F; Docquier, JD; Galleni, M; Gavara, L; Hadjadj, M; Hernandez, JF; Legru, A; Licznar-Fajardo, P; Nauton, L; Sandra Mercuri, P; Sannio, F; Sevaille, L; Verdirosa, F; Vo Hoang, Y1
Abdulhemid Said, L; Muhsin, EA; Sajid Al-Jubori, S1
Chen, L; He, XP; Hong, SJ; Hua, J; Jing, RC; Luo, XY; Xue, HW; Yuan, CY; Yue, Y1
Ho, HC; Huang, C; Li, W; Liu, C; Shi, L; Xia, H; Yang, L; Yang, X; Zeng, Y; Zhang, W1
Ayodo, C; Bollinger, S; Call, DR; Caudell, MA; Ita, T; Kariuki, S; Luvsansharav, U; Mugoh, R; Omulo, S; Palmer, GH; Ramay, BM; Smith, RM; Styczynski, A1

Reviews

1 review(s) available for carbapenems and ro13-9904

ArticleYear
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftriaxone; Cephalosporin Resistance; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Randomized Controlled Trials as Topic

2020

Trials

2 trial(s) available for carbapenems and ro13-9904

ArticleYear
A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A

    Topics: Adult; Carbapenems; Cefotaxime; Ceftriaxone; Humans; Meningitis, Bacterial; Meropenem; Thienamycins; Treatment Outcome

1995
Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Community-Acquired Infections; Costs and Cost Analysis; Drug Combinations; Drug Costs; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Meropenem; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome

2002

Other Studies

30 other study(ies) available for carbapenems and ro13-9904

ArticleYear
Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C

    Topics: Animals; Anti-Bacterial Agents; Blood Bactericidal Activity; Carbapenems; Ceftriaxone; Escherichia coli Infections; Imipenem; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Rabbits

1989
Efficacy of meropenem in experimental meningitis.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A

    Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins

1995
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin

1998
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae

1998
In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteria.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:9

    Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests

1998
In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Glycopeptides; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Streptococcus pneumoniae

1999
In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1

    Topics: Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cephalosporins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

2002
Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Animals; beta-Lactams; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Ertapenem; Female; Imipenem; Intestines; Klebsiella pneumoniae; Mice; Piperacillin; Sodium Chloride; Time Factors; Vancomycin Resistance

2007
Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
    International urology and nephrology, 2012, Volume: 44, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Carbapenems; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatitis; Retrospective Studies; Vancomycin

2012
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections

2012
Impact of penicillin nonsusceptibility on clinical outcomes of patients with nonmeningeal Streptococcus pneumoniae bacteremia in the era of the 2008 clinical and laboratory standards institute penicillin breakpoints.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Child; Child, Preschool; Female; Humans; Infant; Length of Stay; Male; Middle Aged; Penicillin Resistance; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Survival Rate; Treatment Outcome; Vancomycin

2012
Nocardiosis: a 15-year experience in a tertiary medical center in Israel.
    European journal of internal medicine, 2013, Volume: 24, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Aged; Amikacin; Carbapenems; Ceftriaxone; Cohort Studies; Encephalitis; Female; Humans; Immunocompromised Host; Israel; Male; Middle Aged; Nocardia Infections; Pleuropneumonia; Retrospective Studies; Risk Factors; Skin Diseases, Bacterial; Soft Tissue Infections; Tertiary Care Centers; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2013
Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.
    Burns : journal of the International Society for Burn Injuries, 2014, Volume: 40, Issue:2

    Topics: Acinetobacter baumannii; Air Microbiology; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burn Units; Carbapenems; Cefoperazone; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sulbactam

2014
Clinical Impact of Discordant Prescribing of Fluoroquinolones and Alternative Treatments in Escherichia coli Pyelonephritis.
    Journal of pharmacy practice, 2016, Volume: 29, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Guidelines as Topic; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Treatment Outcome

2016
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Molecular Docking Simulation

2015
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
    Critical care (London, England), 2015, Dec-15, Volume: 19

    Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin

2015
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study.
    Critical care (London, England), 2017, 07-15, Volume: 21, Issue:1

    Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Cross-Over Studies; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Monobactams; Pneumonia; Pneumonia, Ventilator-Associated; Prospective Studies; Quinolones; Respiration, Artificial; Statistics, Nonparametric

2017
No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia.
    Scientific reports, 2018, 08-24, Volume: 8, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Female; Genes, Bacterial; Humans; Klebsiella pneumoniae; Male; Mutation; Phylogeny; Virulence; Virulence Factors

2018
Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?
    Journal of global antimicrobial resistance, 2019, Volume: 19

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Nephritis; Retrospective Studies; Spain

2019
Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Enterococcus faecalis; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Polysaccharides

2019
Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
    The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Intestines; Male; Meropenem; Middle Aged; Propensity Score; Retrospective Studies

2019
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
    Scientific reports, 2020, 09-29, Volume: 10, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests

2020
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
    Annals of clinical microbiology and antimicrobials, 2020, Nov-30, Volume: 19, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam

2020
Ceftriaxone versus tazobactam/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:10

    Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Propensity Score; Retrospective Studies

2021
Enhancement of Acinetobacter baumannii biofilm growth by cephem antibiotics via enrichment of protein and extracellular DNA in the biofilm matrices.
    Journal of applied microbiology, 2022, Volume: 133, Issue:3

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Ceftazidime; Ceftriaxone; DNA; Extracellular Polymeric Substance Matrix

2022
1,2,4-Triazole-3-thione analogues with an arylakyl group at position 4 as metallo-β-lactamase inhibitors.
    Bioorganic & medicinal chemistry, 2022, 10-15, Volume: 72

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ceftriaxone; Ethylenes; HeLa Cells; Humans; Ligands; Meropenem; Microbial Sensitivity Tests; Thiones; Triazoles; Zinc

2022
Prevalence of Efflux Pump and Porin-Related Antimicrobial Resistance in Clinical
    Archives of Razi Institute, 2022, Volume: 77, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefazolin; Cefepime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Iraq; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Prevalence

2022
Comparison of the relative efficacy of β-lactam/β-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational cohort study.
    The Journal of antimicrobial chemotherapy, 2023, 03-02, Volume: 78, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Lactams; Retrospective Studies; Urinary Tract Infections

2023
Estimating the effect of increasing ambient temperature on antimicrobial resistance in China: A nationwide ecological study with the difference-in-differences approach.
    The Science of the total environment, 2023, Jul-15, Volume: 882

    Topics: Anti-Bacterial Agents; Carbapenems; Cefotaxime; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Quinolones; Temperature

2023
Risk Factors for Colonization With Extended-Spectrum Cephalosporin-Resistant and Carbapenem-Resistant Enterobacterales Among Hospitalized Patients in Kenya: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 07-05, Volume: 77, Issue:Suppl 1

    Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Microbial; Hospitals; Humans; Kenya; Monobactams; Risk Factors

2023